{"altmetric_id":2325082,"counts":{"readers":{"mendeley":22,"citeulike":0,"connotea":0},"facebook":{"unique_users_count":1,"unique_users":["100004274083016"],"posts_count":1},"total":{"posts_count":7},"twitter":{"unique_users_count":2,"unique_users":["syuichiao","TripPrimaryCare"],"posts_count":6}},"citation":{"abstract":"This study evaluated health status and health-related quality of life (HRQOL) among patients with type 2 diabetes mellitus (T2DM) treated with dapagliflozin, a highly selective sodium-glucose co-transporter 2 (SGLT2) inhibitor that lowers blood glucose by increasing glucose excretion, in a double-blind, randomised clinical trial.","abstract_source":"pubmed","altmetric_jid":"4f6fa5e73cf058f61000599d","authors":["Grandy S","Langkilde AM","Sugg JE","Parikh S","Sj\u00f6str\u00f6m CD"],"doi":"10.1111\/ijcp.12341","first_seen_on":"2014-05-04T18:01:27+00:00","issns":["1368-5031"],"issue":"","journal":"International journal of clinical practice","last_mentioned_on":1402839396,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24499168?dopt=Abstract","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24499168"],"pmid":"24499168","pubdate":"2014-02-08T00:00:00+00:00","publisher":"Blackwell Publishing Ltd","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"subjects":["medicine"],"title":"Health-related quality of life (EQ-5D) among type 2 diabetes mellitus patients treated with dapagliflozin over 2\u00a0years.","type":"article","volume":"","mendeley_url":"http:\/\/www.mendeley.com\/research\/healthrelated-quality-life-eq5d-among-type-2-diabetes-mellitus-patients-treated-dapagliflozin-2-year-3"},"altmetric_score":{"score":1,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":1},"context_for_score":{"all":{"total_number_of_other_articles":4507211,"mean":5.1317416223105,"rank":2309718,"this_scored_higher_than_pct":35,"this_scored_higher_than":1582133,"rank_type":"exact","sample_size":4507211,"percentile":35},"similar_age_3m":{"total_number_of_other_articles":108971,"mean":7.6537012205196,"rank":53595,"this_scored_higher_than_pct":35,"this_scored_higher_than":38250,"rank_type":"exact","sample_size":108971,"percentile":35},"this_journal":{"total_number_of_other_articles":770,"mean":4.1614564369311,"rank":402,"this_scored_higher_than_pct":33,"this_scored_higher_than":257,"rank_type":"exact","sample_size":770,"percentile":33},"similar_age_this_journal_3m":{"total_number_of_other_articles":13,"mean":1.875,"rank":6,"this_scored_higher_than_pct":38,"this_scored_higher_than":5,"rank_type":"exact","sample_size":13,"percentile":38}}},"demographics":{"poster_types":{"member_of_the_public":2},"users":{"twitter":{"cohorts":{"Members of the public":2}},"mendeley":{"by_status":{"Unspecified":1,"Librarian":2,"Researcher":3,"Student  > Postgraduate":4,"Other":4,"Student  > Master":4,"Student  > Bachelor":3,"Lecturer":1},"by_discipline":{"Medicine and Dentistry":12,"Agricultural and Biological Sciences":1,"Nursing and Health Professions":1,"Unspecified":1,"Pharmacology, Toxicology and Pharmaceutical Science":7}}},"geo":{"mendeley":{"CA":1}}},"posts":{"facebook":[{"title":"Health-related quality of life (EQ-5D) amon... [Int J Clin Pract. 2014] - PubMed - NCBI","url":"https:\/\/www.facebook.com\/100004274083016\/posts\/338821836270283","license":"public","citation_ids":[2325082],"posted_on":"2014-06-15T12:34:54+00:00","summary":"Health-related quality of life (EQ-5D) among type 2 diabetes mellitus patients treated with dapagliflozin over 2 years.\nInt J Clin Pract. 2014 Apr;68(4):486-94.\nhttp:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24499168\n\nDapagliflozin, a novel SGLT2 inhibitor, did not ad","author":{"name":"Syuichi  Aoshima","url":"https:\/\/www.facebook.com\/100004274083016","facebook_wall_name":false,"image":"https:\/\/graph.facebook.com\/100004274083016\/picture","id_on_source":"100004274083016"}}],"twitter":[{"url":"http:\/\/twitter.com\/syuichiao\/status\/478156018602369025","license":"datasift","citation_ids":[2325082],"posted_on":"2014-06-15T12:44:13+00:00","author":{"name":"\u9752\u5cf6\u5468\u4e00","url":"http:\/\/syuichiao.hatenadiary.com\/archive","image":"https:\/\/pbs.twimg.com\/profile_images\/887157273524551681\/ZauwIxQv_normal.jpg","description":"\u85ac\u5264\u5e2b\u3067\u3059\u304c\u54f2\u5b66\u306b\u8208\u5473\u304c\u3042\u308a\u307e\u3059\u3002NPO\u6cd5\u4ebaAHEADMAP\u306e\u5171\u540c\u4ee3\u8868\u3084\u3063\u3066\u307e\u3059\u3002AHEADMAP\u516c\u5f0f\uff28\uff30\u25b6https:\/\/aheadmap.jimdo.com\/\u3000\u8457\u66f8\u25b6ISBN-10: 4822200981","id_on_source":"syuichiao","tweeter_id":"513975225","geo":{"lt":null,"ln":null},"followers":2828},"tweet_id":"478156018602369025"},{"url":"http:\/\/twitter.com\/syuichiao\/status\/478161289802313730","license":"datasift","citation_ids":[2325082],"posted_on":"2014-06-15T13:05:09+00:00","author":{"name":"\u9752\u5cf6\u5468\u4e00","url":"http:\/\/syuichiao.hatenadiary.com\/archive","image":"https:\/\/pbs.twimg.com\/profile_images\/887157273524551681\/ZauwIxQv_normal.jpg","description":"\u85ac\u5264\u5e2b\u3067\u3059\u304c\u54f2\u5b66\u306b\u8208\u5473\u304c\u3042\u308a\u307e\u3059\u3002NPO\u6cd5\u4ebaAHEADMAP\u306e\u5171\u540c\u4ee3\u8868\u3084\u3063\u3066\u307e\u3059\u3002AHEADMAP\u516c\u5f0f\uff28\uff30\u25b6https:\/\/aheadmap.jimdo.com\/\u3000\u8457\u66f8\u25b6ISBN-10: 4822200981","id_on_source":"syuichiao","tweeter_id":"513975225","geo":{"lt":null,"ln":null},"followers":2828},"tweet_id":"478161289802313730"},{"url":"http:\/\/twitter.com\/syuichiao\/status\/478169202696544256","license":"datasift","citation_ids":[2325082],"posted_on":"2014-06-15T13:36:36+00:00","author":{"name":"\u9752\u5cf6\u5468\u4e00","url":"http:\/\/syuichiao.hatenadiary.com\/archive","image":"https:\/\/pbs.twimg.com\/profile_images\/887157273524551681\/ZauwIxQv_normal.jpg","description":"\u85ac\u5264\u5e2b\u3067\u3059\u304c\u54f2\u5b66\u306b\u8208\u5473\u304c\u3042\u308a\u307e\u3059\u3002NPO\u6cd5\u4ebaAHEADMAP\u306e\u5171\u540c\u4ee3\u8868\u3084\u3063\u3066\u307e\u3059\u3002AHEADMAP\u516c\u5f0f\uff28\uff30\u25b6https:\/\/aheadmap.jimdo.com\/\u3000\u8457\u66f8\u25b6ISBN-10: 4822200981","id_on_source":"syuichiao","tweeter_id":"513975225","geo":{"lt":null,"ln":null},"followers":2828},"tweet_id":"478169202696544256"},{"url":"http:\/\/twitter.com\/syuichiao\/status\/478169115505340416","license":"datasift","citation_ids":[2325082],"posted_on":"2014-06-15T13:36:15+00:00","author":{"name":"\u9752\u5cf6\u5468\u4e00","url":"http:\/\/syuichiao.hatenadiary.com\/archive","image":"https:\/\/pbs.twimg.com\/profile_images\/887157273524551681\/ZauwIxQv_normal.jpg","description":"\u85ac\u5264\u5e2b\u3067\u3059\u304c\u54f2\u5b66\u306b\u8208\u5473\u304c\u3042\u308a\u307e\u3059\u3002NPO\u6cd5\u4ebaAHEADMAP\u306e\u5171\u540c\u4ee3\u8868\u3084\u3063\u3066\u307e\u3059\u3002AHEADMAP\u516c\u5f0f\uff28\uff30\u25b6https:\/\/aheadmap.jimdo.com\/\u3000\u8457\u66f8\u25b6ISBN-10: 4822200981","id_on_source":"syuichiao","tweeter_id":"513975225","geo":{"lt":null,"ln":null},"followers":2828},"tweet_id":"478169115505340416"},{"url":"http:\/\/twitter.com\/TripPrimaryCare\/status\/463015500729954305","license":"datasift","citation_ids":[2325082],"posted_on":"2014-05-04T18:01:12+00:00","author":{"name":"Trip Primary Care","image":"https:\/\/pbs.twimg.com\/profile_images\/429598293052497922\/tEinrVIC_normal.jpeg","description":"All the latest primary care evidence, added to the Trip Database. Tweets are not endorsements","id_on_source":"TripPrimaryCare","tweeter_id":"2199494760","geo":{"lt":null,"ln":null},"followers":2133},"tweet_id":"463015500729954305"},{"url":"http:\/\/twitter.com\/syuichiao\/status\/478153010816630785","license":"datasift","citation_ids":[2325082],"posted_on":"2014-06-15T12:32:16+00:00","author":{"name":"\u9752\u5cf6\u5468\u4e00","url":"http:\/\/syuichiao.hatenadiary.com\/archive","image":"https:\/\/pbs.twimg.com\/profile_images\/887157273524551681\/ZauwIxQv_normal.jpg","description":"\u85ac\u5264\u5e2b\u3067\u3059\u304c\u54f2\u5b66\u306b\u8208\u5473\u304c\u3042\u308a\u307e\u3059\u3002NPO\u6cd5\u4ebaAHEADMAP\u306e\u5171\u540c\u4ee3\u8868\u3084\u3063\u3066\u307e\u3059\u3002AHEADMAP\u516c\u5f0f\uff28\uff30\u25b6https:\/\/aheadmap.jimdo.com\/\u3000\u8457\u66f8\u25b6ISBN-10: 4822200981","id_on_source":"syuichiao","tweeter_id":"513975225","geo":{"lt":null,"ln":null},"followers":2828},"tweet_id":"478153010816630785"}]}}